Command Palette

Search for a command to run...

Clinical Trials · NCT01513525

Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers

CompletedPhase 1Liraglutide (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
Novo Nordisk A/S
Enrollment
21
Start date
Feb 2007
Locations
1 site, Germany
Primary endpoint
Area under the Curve (AUC) of liraglutide for each injection site
View Liraglutide compound reference